The Release of Membrane Vesicles with Mature MicroRNA-221 and Activated Caspase-3 by Platelets during Storage of Platelet Concentrate


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

The preparation and storage of platelet concentrate can be accompanied by activation of platelets and triggering of apoptosis, increasing the formation of platelet membrane vesicles and worsening the therapeutic properties of such preparations. However, the mechanisms for the regulation of apoptosis in platelets and the molecular composition of platelet membrane vesicles associated with this process have so far remained poorly understood. The aim of the work was to study proapoptotic caspase-3 and antiapoptotic microRNA-221 levels in platelets and platelet membrane vesicles during the storage of platelet concentrate preparations. The object of the study was samples of the pooled platelet concentrates (n = 6), taken from the containers on the second and seventh days of storage. Full length and activated caspase-3 were found in platelets and in fractions of membrane vesicles. The proportion of activated caspase-3 in platelets increased during storage. MicroRNA-221 was found in platelets, fractions of membrane vesicles, as well as in the extravesicular fraction. During storage, levels of microRNA-221 increased 8-fold (P = 0.004) in the fraction of membrane vesicles pelleted at 100 000 g. The results of the study indicate that the membrane vesicles released by platelets during storage contain mature microRNA-221 and the activated form of caspase-3.

About the authors

V. V. Kishenko

Almazov National Medical Research Center of the Ministry of Health of the Russian Federation

Email: olga_sirotkina@mail.ru
Russian Federation, St. Petersburg, 197341

K. A. Kondratov

Almazov National Medical Research Center of the Ministry of Health of the Russian Federation

Email: olga_sirotkina@mail.ru
Russian Federation, St. Petersburg, 197341

V. Yu. Mikhailovsky

St. Petersburg State University, Interdisciplinary Resource Center for Nanotechnology

Email: olga_sirotkina@mail.ru
Russian Federation, St. Petersburg, 199034

S. V. Sidorkevich

Almazov National Medical Research Center of the Ministry of Health of the Russian Federation

Email: olga_sirotkina@mail.ru
Russian Federation, St. Petersburg, 197341

T. V. Vavilova

Almazov National Medical Research Center of the Ministry of Health of the Russian Federation

Email: olga_sirotkina@mail.ru
Russian Federation, St. Petersburg, 197341

O. V. Sirotkina

Almazov National Medical Research Center of the Ministry of Health of the Russian Federation; Petersburg Nuclear Physics Institute Named after Konstantinov, National Research Center Kurchatov Institute,; Pavlov First St. Petersburg State Medical University of the Ministry of Healthcare of the Russian Federation

Author for correspondence.
Email: olga_sirotkina@mail.ru
Russian Federation, St. Petersburg, 197341; Gatchina, Leningrad oblast, 188300; St. Petersburg, 197022

A. V. Fedorov

Almazov National Medical Research Center of the Ministry of Health of the Russian Federation

Email: olga_sirotkina@mail.ru
Russian Federation, St. Petersburg, 197341

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2018 Pleiades Publishing, Ltd.